Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Robert Williams, Jr. Sells 1,000,000 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 1,000,000 shares of the stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total value of $8,000,000.00. Following the completion of the transaction, the insider owned 245,251 shares of the company’s stock, valued at approximately $1,962,008. This trade represents a 80.31% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Stock Up 1.5%

Shares of AVAH stock traded up $0.12 during mid-day trading on Friday, reaching $8.61. 953,109 shares of the company’s stock traded hands, compared to its average volume of 1,436,922. The company’s 50-day moving average price is $7.10 and its 200-day moving average price is $7.57. The company has a market cap of $1.87 billion, a P/E ratio of 7.29, a P/E/G ratio of 0.87 and a beta of 1.93. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.73 and a 12 month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The company had revenue of $647.91 million during the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare’s revenue was up 15.9% on a year-over-year basis. On average, equities analysts expect that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. AustralianSuper Pty Ltd bought a new position in Aveanna Healthcare in the 3rd quarter worth $15,743,000. Vanguard Group Inc. raised its holdings in Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after acquiring an additional 1,535,351 shares during the period. Algert Global LLC lifted its position in shares of Aveanna Healthcare by 120.1% in the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock valued at $9,070,000 after acquiring an additional 557,898 shares in the last quarter. Quantbot Technologies LP boosted its stake in shares of Aveanna Healthcare by 1,220.8% in the third quarter. Quantbot Technologies LP now owns 109,707 shares of the company’s stock worth $973,000 after acquiring an additional 101,401 shares during the period. Finally, UBS Group AG grew its position in shares of Aveanna Healthcare by 149.4% during the fourth quarter. UBS Group AG now owns 394,182 shares of the company’s stock worth $3,220,000 after purchasing an additional 236,152 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on AVAH shares. Truist Financial boosted their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research note on Wednesday, June 3rd. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $10.00 to $11.00 in a report on Friday, May 15th. BMO Capital Markets cut their target price on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, March 20th. Finally, Weiss Ratings downgraded Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Aveanna Healthcare currently has an average rating of “Moderate Buy” and an average price target of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.